FDA Inspection 1178628 — Charles Wykoff, M.D., PhD
The FDA completed an inspection of Charles Wykoff, M.D., PhD on Aug 26, 2022 in The Woodlands, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 26, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- The Woodlands, TX (United States)
Additional Details
Clinical Investigator (CI)